Literature DB >> 24329681

Fundus autofluorescence imaging in multifocal choroiditis: beyond the spots.

Michal Kramer1, Ethan Priel.   

Abstract

PURPOSE: To describe fundus autofluorescence (FAF) imaging and its correlation to spectral-domain optical coherence tomography (SD-OCT) in retinal areas that appear clinically noninvolved in patients with multifocal choroiditis/punctate inner choroidopathy (MFC/PIC).
METHODS: Six patients with MFC or PIC were evaluated during the disease course with multimodal imaging, which included fluorescein angiography, FAF imaging, indocyanine green angiography, and SD-OCT.
RESULTS: Five patients had acute and/or scarred chorioretinal spots at presentation. Five patients had choroidal neovascularization. FAF imaging in all patients disclosed diffuse peripapillary and/or posterior-pole hyperautofluorescent plaques in areas that appeared clinically to be noninvolved. Corresponding SD-OCT scans revealed severe disruption of the inner segment/outer segment junction. Findings resolved with corticosteroid treatment Conclusions: FAF imaging of patients with MFC/PIC reveals extensive pathology beyond the clinically apparent spots. FAF findings highlight the areas of corresponding anatomic disruption of the photoreceptor-retinal pigment epithelium complex.

Entities:  

Keywords:  Fundus autofluorescence (FAF); multifocal choroiditis (MFC); punctate inner choroidopathy (PIC); spectral-domain-OCT (SD-OCT)

Mesh:

Substances:

Year:  2013        PMID: 24329681     DOI: 10.3109/09273948.2013.855797

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  11 in total

Review 1.  Immunosuppression for the Uveitides.

Authors:  Douglas A Jabs
Journal:  Ophthalmology       Date:  2017-09-20       Impact factor: 12.079

2.  [White dot syndromes : Principles, diagnostics, and treatment].

Authors:  Dominika Pohlmann; Sibylle Winterhalter; Uwe Pleyer
Journal:  Ophthalmologe       Date:  2019-12       Impact factor: 1.059

3.  Analysis of autofluorescence pattern in birdshot chorioretinopathy.

Authors:  R Semécas; M Mauget-Faÿsse; F Aptel; A Mailhac; L Salmon; V Vasseur; L Bouillet; C Chiquet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-27       Impact factor: 3.117

4.  Idiopathic multifocal choroiditis/punctate inner choroidopathy with acute photoreceptor loss or dysfunction out of proportion to clinically visible lesions.

Authors:  Marion R Munk; Jesse J Jung; Kristin Biggee; William R Tucker; H Nida Sen; Ursula Schmidt-Erfurth; Amani A Fawzi; Lee M Jampol
Journal:  Retina       Date:  2015-02       Impact factor: 4.256

Review 5.  Fundus autofluorescence imaging: systematic review of test accuracy for the diagnosis and monitoring of retinal conditions.

Authors:  G K Frampton; N Kalita; L Payne; J L Colquitt; E Loveman; S M Downes; A J Lotery
Journal:  Eye (Lond)       Date:  2017-03-10       Impact factor: 3.775

Review 6.  Mechanisms, Pathophysiology and Current Immunomodulatory/Immunosuppressive Therapy of Non-Infectious and/or Immune-Mediated Choroiditis.

Authors:  Ioannis Papasavvas; Ilknur Tugal-Tutkun; Carl P Herbort
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-24

7.  Multimodal Imaging of the White Dot Syndromes and Related Diseases.

Authors:  Jared E Knickelbein; H Nida Sen
Journal:  J Clin Exp Ophthalmol       Date:  2016-06-27

8.  Multifocal Choroiditis with Retinal Vasculitis, Optic Neuropathy, and Keratoconus in a Young Saudi Male.

Authors:  Yousef Dhafiri; Khalid Al Rubaie; Omar Kirat; William N May; Quan D Nguyen; Igor Kozak
Journal:  Middle East Afr J Ophthalmol       Date:  2017 Apr-Jun

Review 9.  Classification of Non-Infectious and/or Immune Mediated Choroiditis: A Brief Overview of the Essentials.

Authors:  Carl P Herbort; Alessandro Mantovani; Ilknur Tugal-Tutkun; Ioannis Papasavvas
Journal:  Diagnostics (Basel)       Date:  2021-05-24

10.  Imageology features of different types of multifocal choroiditis.

Authors:  Juanjuan Li; Yunpeng Li; Hua Li; Liwei Zhang
Journal:  BMC Ophthalmol       Date:  2019-02-01       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.